Healthcare Analysts provide an update on Pulsed-Field Ablation (PFA) and discuss what is expected from Boston Scientific’s (BSX) ADVENT Trial, as well as other expectations for the upcoming ESC Congress 2023 on an Analyst/Industry conference call to be held on August 16 at 11 am. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BSX:
- Unusually active option classes on open August 16th
- Boston Scientific put volume heavy and directionally bearish
- Boston Scientific announces FDA approval of the POLARx Cryoablation System
- Boston Scientific selloff brings ‘excellent entry point,’ says JPMorgan
- Boston Scientific call volume above normal and directionally bullish